• News by Topic

  • News by Topic

  • Relationships news

  • Mind and body

    "Live as if your were to die tomorrow. Learn as if you were to live forever. You must learn to be still in the midst of activity and be vibrantly alive in repose."

    --Gandhi

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Vote!

Study Suggests Escitalopram May Reduce Inflammatory, Neurotoxic Biomarkers

In addition to alleviating symptoms of depression in some people, the selective-serotonin reuptake inhibitor (SSRI) escitalopram may protect against some inflammatory and neurotoxic biomarkers associated with the mood disorder, a study in the Journal of Psychiatric Research reports.Angelos Halaris, M.D., Ph.D., a professor of psychiatry and behavioral neurosciences at Loyola University Chicago Stritch School of Medicine, and colleagues compared blood samples from 30 adults with MDD taking 20 to 40 mg of escitalopram daily for 12 weeks with those obtained from 27 controls. The researchers assessed plasma levels of inflammatory...

read more...

Share |

Published By: Psychiatric News - Wednesday, 2 December, 2015

Copyright © 2016 Psychology One. All rights reserved. This site is for education & information purposes. This site is not a substitute for professional psychological, medical or psychiatric treatment.